|
|
Article: Newer antipsychotics associated with lower mortality than haloperidol in elderly.
- Article from:
- Health & Medicine Week
- Article date:
- August 2, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Elderly patients whose psychosis is treated with conventional drugs may be much more likely to die than those who receive a relatively new generation of treatments, according to a new study.
Researchers led by Henry A. Nasrallah, MD, of the University of Cincinnati compared deaths during a 2-year period among patients 65 years or older who were receiving either a conventional medication (haloperidol) or one of two so-called "atypical" therapies (risperidone or olanzapine) for Alzheimer dementia and other age-related psychoses. The study was published in the July-August 2004 issue of the American Journal of Geriatric ...